KRONOS IV Get Research Funding For Impotence Cure
Written by Jamie Stowe | Tuesday, 27 October 2009 | There are 0 comments
From humble beginnings something great may come out of the pharmaceutical pipeline in years to come. Professor Nestor Gonzalez-Cadavid working at the Los Angeles Biomedical Institute has just been awarded $1.2million to help him undertake research with a new erectile dysfunction medication. By the pharmaceutical industry standard this is a tiny amount of money, but who knows maybe it will produce great things?

Professor Gonzalez-Cadavid is hoping to come across a long term cure for erectile dysfunction with a drug named KRONOS IV which has already been approved for other applications. He is banking on the fact that this drug can be used instead of surgery to rebuild penile tissues which disintegrate over time due to a natural ageing process. Professor Gonzalez-Cadavid has already achieved considerable success in his profession with his groundbreaking work on surgical interventions to treat impotence. The research which was funded by the manufacturer of KRONOS IV, Endogenous Stem Cells Activators should produce clinical results in around a year’s time.
The world’s most famous erectile dysfunction medication Viagra also had humble beginnings when it was originally developed as a treatment for angina and clinical testing was initiated in Wales. It was only when men started reporting incredible differences in their sexual function that Pfizer realised that they had stumbled on something which was to revolutionise the lives of millions of men around the world.
Practically all great drug inventions are stumbled upon by accident and that is why clinical testing is so important because it is only when risks are taken and scientists are allowed to experiment in different areas that knowledge is gained. Ukmedix News makes it a point to keep up to date with all new treatments for erectile dysfunction and we will let our readers know if any positive findings are produced with KRONOS IV.


